'AmeriSource, Bergen Brunswig to merge

20 March 2001

AmeriSource Health Corp and Bergen Brunswig Corp have agreed to merge ina deal that would create the largest wholesale drug distributor in the USA.The merged company, which will be called AmeriSource-Bergen, will generate $35 billion in annual revenues and have a market capitalization of around $4.5 billion.

The new group, which will be 51%-owned by AmeriSource shareholders, will have a 10-member board, with the latter's chief executive, David Yost, holding the same role. His counterpart at Bergen Brunswig, Robert Martini, will become chairman, and he said that the merged company will provide "greater depth of product offerings."

FTC to scupper deal?

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight